Literature DB >> 18456180

Natural history of primary biliary cirrhosis.

Marlyn J Mayo1.   

Abstract

Primary biliary cirrhosis is an insidious disease that progresses through the clinical phases: preclinical, asymptomatic, symptomatic, and liver insufficiency. The outlook of patients diagnosed with PBC has improved significantly over the past 2 decades because more patients are being diagnosed earlier in the disease process and being treated with UDCA. A need remains to better define and predict the course of symptomatic and asymptomatic patients on and off UDCA in order to better evaluate outcomes of clinical trials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456180     DOI: 10.1016/j.cld.2008.02.012

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  15 in total

1.  Methotrexate for primary biliary cirrhosis: who is to be trusted?

Authors:  Carlo Selmi; Mauro Podda
Journal:  Dig Dis Sci       Date:  2010-11       Impact factor: 3.199

2.  Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.

Authors:  Chao-Jun Hu; Guang Song; Wei Huang; Guo-Zhen Liu; Chui-Wen Deng; Hai-Pan Zeng; Li Wang; Feng-Chun Zhang; Xuan Zhang; Jun Seop Jeong; Seth Blackshaw; Li-Zhi Jiang; Heng Zhu; Lin Wu; Yong-Zhe Li
Journal:  Mol Cell Proteomics       Date:  2012-05-30       Impact factor: 5.911

3.  Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome.

Authors:  Eirini I Rigopoulou; Kalliopi Zachou; Nikolaos K Gatselis; Georgia Papadamou; George K Koukoulis; George N Dalekos
Journal:  World J Hepatol       Date:  2013-10-27

4.  The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis.

Authors:  Zongwen Shuai; Jinjun Wang; Madhu Badamagunta; Jinjung Choi; Guoxiang Yang; Weici Zhang; Thomas P Kenny; Kathryn Guggenheim; Mark J Kurth; Aftab A Ansari; John Voss; Ross L Coppel; Pietro Invernizzi; Patrick S C Leung; M Eric Gershwin
Journal:  Hepatology       Date:  2017-03-31       Impact factor: 17.425

Review 5.  Xenobiotics and loss of tolerance in primary biliary cholangitis.

Authors:  Jinjun Wang; Guoxiang Yang; Alana Mari Dubrovsky; Jinjung Choi; Patrick S C Leung
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 6.  A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis.

Authors:  Patrick S C Leung; Jinjung Choi; Guoxiang Yang; Elena Woo; Thomas P Kenny; M Eric Gershwin
Journal:  Expert Rev Mol Diagn       Date:  2016-03-30       Impact factor: 5.225

7.  Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA.

Authors:  Patrick S C Leung; Jinjun Wang; Phornnop Naiyanetr; Thomas P Kenny; Kit S Lam; Mark J Kurth; M Eric Gershwin
Journal:  J Autoimmun       Date:  2013-01-24       Impact factor: 7.094

Review 8.  [Autoimmune liver diseases].

Authors:  S Lüth; C Weiler-Normann; C Schramm; A W Lohse
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

9.  Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis?

Authors:  Patrick S C Leung; Kit Lam; Mark J Kurth; Ross L Coppel; M Eric Gershwin
Journal:  Trends Mol Med       Date:  2012-08-21       Impact factor: 11.951

Review 10.  Granulomatous liver disease.

Authors:  Sidharth S Bhardwaj; Romil Saxena; Paul Y Kwo
Journal:  Curr Gastroenterol Rep       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.